How an experimental cancer drug leaves the body
This study tracks how an experimental cancer drug leaves the body in healthy men. It helps researchers understand how the drug is processed, which is important for future dosing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy male aged 18 to 45 years.
- Weigh at least 50 kg (about 110 pounds) and have a body mass index (BMI) between 19 and 26.
- Not have known allergies to two or more substances, or allergic diseases.
- Not have frequent constipation, diarrhea, or a problem with absorbing food.
- Not have taken any experimental drug or joined another clinical trial in the last 3 months.
- Not have alcohol or drug dependence.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how a new drug, called FXS4640, moves through the body in healthy men. It uses a small amount of radioactivity to follow the drug, which helps researchers understand how it is absorbed and cleared. Participation involves staying at the clinic for several days for tests and samples.
This trial is for healthy men to see how the body processes an experimental drug. It will help researchers understand how the drug is absorbed, broken down, and removed from the body.
This study looks at how a new medicine is broken down and removed from the body in healthy men. It helps researchers understand the drug's safety and how it works.
This trial tests a new drug called Purinostat Mesylate, either alone or combined with other drugs, in people with advanced solid tumors (including breast cancer) that have not responded to standard treatments. The goal is to see if the drug can help shrink tumors or slow their growth.
This study gives healthy men a single dose of a new medication that has a tiny radioactive marker, so researchers can track how it leaves the body through urine and stool. It helps understand how the drug is processed and safe, which is a necessary step before it can be tested in patients.
This study gives healthy volunteers a small, safe dose of a radiolabeled (radioactive) drug to see how it is absorbed, broken down, and removed from the body. By participating, you help researchers understand the drug's behavior, which informs future dosing and safety.
Hear when a new MB trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.